Literature DB >> 10409562

Nitric oxide donors can increase heart rate independent of autonomic activation.

N Hogan1, B Casadei, D J Paterson.   

Abstract

Administration of nitric oxide (NO) donors in vivo is accompanied by a baroreflex-mediated increase in heart rate (HR). In vitro, however, NO donors can increase HR directly by stimulating a pathway that involves NO, cGMP, and the hyperpolarization-activated current (I(f)). The aim of this study was to assess the functional significance of this pathway in vivo by testing whether NO donors can increase HR in the anesthetized rabbit independent of the autonomic nervous system. New Zealand White rabbits were vagotomized, cardiac sympathectomized, and treated with propranolol (0.3 mg/kg iv). The NO donor molsidomine (0.2 mg/kg iv) caused a progressive increase (Delta) in HR (DeltaHR, 14 +/- 3 beats/min; P < 0.01). This effect was significantly reduced by the I(f) blocker ZD-7288 (0.2 mg/kg iv; DeltaHR, 2 +/- 3 beats/min; P = not significant). Similar results were seen with sodium nitroprusside. The positive chronotropic effect of sodium nitroprusside (50 microM) was confirmed in the isolated working rabbit heart preparation (DeltaHR, 17 +/- 3 beats/min; P < 0.01). In conclusion, NO donors exert a small, but significant, positive chronotropic effect in vivo that is independent of the autonomic nervous system. These results are also consistent with data in sinoatrial node cells that show that NO donors increase HR by stimulating I(f).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10409562     DOI: 10.1152/jappl.1999.87.1.97

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  11 in total

1.  Mechanical and neural contributions to hysteresis in the cardiac vagal limb of the arterial baroreflex.

Authors:  Péter Studinger; Richard Goldstein; J Andrew Taylor
Journal:  J Physiol       Date:  2007-07-19       Impact factor: 5.182

2.  Baroreflex physiology studied in healthy subjects with very infrequent muscle sympathetic bursts.

Authors:  André Diedrich; Alexandra A Crossman; Larry A Beightol; Kari U O Tahvanainen; Tom A Kuusela; Andrew C Ertl; Dwain L Eckberg
Journal:  J Appl Physiol (1985)       Date:  2012-11-29

3.  Isoform-specific regulation of HCN4 channels by a family of endoplasmic reticulum proteins.

Authors:  Colin H Peters; Mallory E Myers; Julie Juchno; Charlie Haimbaugh; Hicham Bichraoui; Yanmei Du; John R Bankston; Lori A Walker; Catherine Proenza
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-09       Impact factor: 11.205

4.  Exogenous intravascular nitric oxide enhances ventricular function after hemodilution with plasma expander.

Authors:  Surapong Chatpun; Pedro Cabrales
Journal:  Life Sci       Date:  2011-10-26       Impact factor: 5.037

5.  Role of nitric oxide in regulating cardiac electrophysiology.

Authors:  L Wang
Journal:  Exp Clin Cardiol       Date:  2001

6.  Development of baroreflex and endocrine responses to hypotensive stress in newborn foals and lambs.

Authors:  S J O'Connor; D S Gardner; J C Ousey; N Holdstock; P Rossdale; C M B Edwards; A L Fowden; D A Giussani
Journal:  Pflugers Arch       Date:  2005-06-02       Impact factor: 3.657

7.  Chronotropic effects of nitric oxide in the denervated human heart.

Authors:  S Chowdhary; D Harrington; R S Bonser; J H Coote; J N Townend
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

8.  Development of baroreflex function and hind limb vascular reactivity in the horse fetus.

Authors:  Susie J O'Connor; Jenny C Ousey; David S Gardner; Abigail L Fowden; Dino A Giussani
Journal:  J Physiol       Date:  2006-02-09       Impact factor: 5.182

Review 9.  Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?

Authors:  Claire E Sears; Euan A Ashley; Barbara Casadei
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

10.  A comparison of pharmacologic and spontaneous baroreflex methods in aging and hypertension.

Authors:  Milos Milic; Ping Sun; Fujun Liu; Claudia Fainman; Joel Dimsdale; Paul J Mills; Michael G Ziegler
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.